Device
Continuous Glucose Sensor
Continuous Glucose Sensor is a medical device with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
1
33%
Ph early_phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
unknown1
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown133%
completed133%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
unknown
Accuracy of CGM in the ICU, Compared to Standard of Care
NCT04352907
terminatedearly_phase_1
Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?
NCT01954459
completednot_applicable
Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control
NCT00945659
Clinical Trials (3)
Showing 3 of 3 trials
NCT04352907
Accuracy of CGM in the ICU, Compared to Standard of Care
NCT01954459Early Phase 1
Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?
NCT00945659Not Applicable
Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3